Key result
Lisinopril alone and combined with simvastatin normalized erythrocyte arginase activity and increased plasma nitric oxide metabolites in 100% of patients with atherosclerosis and hypertension.
Why the study?
Does lisinopril plus simvastatin improve erythrocyte and plasma arginase and nitric oxide metabolites compared to lisinopril alone in patients with atherosclerosis and hypertension?
RCT
Does lisinopril plus simvastatin improve erythrocyte and plasma arginase and nitric oxide metabolites compared to lisinopril alone in patients with atherosclerosis and hypertension?
Lisinopril alone and in combination with simvastatin equally normalize erythrocyte arginase and nitric oxide synthase activities in hypertensive patients with atherosclerosis.
Answers are grounded in this paper and cite their sources.
Lisinopril alone matches combination therapy for biomarker normalization; extends evidence of statin-independent effects in hypertensive atherosclerosis.
Angiotensin-converting enzyme inhibitors are effective at reducing blood pressure, whereas statins decrease plasma cholesterol, impeding atherosclerosis. The authors hypothesize that these medications may improve blood pressure by modifying the arginase-nitric oxide synthase system of erythrocytes. In this study, the effects of lisinopril alone versus lisinopril + simvastatin on erythrocyte and plasma arginase enzyme and nitric oxide metabolites are compared. Patients with atherosclerosis and hypertension are randomly assigned to receive lisinopril 10 to 20 mg/d or lisinopril 10 to 20 mg/d plus simvastatin 20 mg/d for 24 weeks. Higher arginase activity is observed in erythrocytes from 100% of patients and mainly recovered after 12 and 24 weeks of treatment with lisinopril or lisinopril + simvastatin. Plasma arginase activity is 3 orders of magnitude lower than erythrocyte arginase activity in all participants, suggesting a lack of its clinical significance. Both treatments cause the increase in plasma N O ₂⁻ , N O ₃⁻ , and N O ₂⁻ + N O ₃⁻ in 100% of patients. Erythrocyte N O ₂⁻ + N O ₃⁻ concentration is greatly decreased in hypertensive patients but recovers after monotherapy and combined therapy. The results show for the first time that lisinopril monotherapy and combined lisinopril + simvastatin therapy exhibit pronounced and equipotential normalizing effects on erythrocyte arginase and nitric oxide synthase activities.
No takes yet. Share an insight, caveat, or question.
Kosenko et al. (2011) conducted an RCT in Atherosclerosis and hypertension. Lisinopril plus simvastatin vs. Lisinopril 10 to 20 mg/d alone was evaluated on Erythrocyte and plasma arginase enzyme and nitric oxide metabolites. Lisinopril alone and combined with simvastatin normalized erythrocyte arginase activity and increased plasma nitric oxide metabolites in 100% of patients with atherosclerosis and hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: